Aandeel ISCO INTERNATIONAL STEM CELL CORP
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen International Stem Cell Corp OTC Bulletin Board

Aandelen

ISCO

US4603781026

slotkoers OTC Bulletin Board
Andere beurzen
- USD - Intraday-grafiek van International Stem Cell Corp
28/03 International Stem Cell Corporation rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023 CI
2023 International Stem Cell Corporation rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
International Stem Cell Corporation and Dr. Andrey Semechkin Agrees to Extend (Until September 15, 2024) the Maturity Date of the Loan
Bayer says Parkinson's stem cell therapy improves symptoms in initial trial
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Bayer claims early lead in Parkinson's stem cell therapy
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
INTERNATIONAL STEM CELL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
International Stem Cell Corporation Auditor Raises 'Going Concern' Doubt
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ISCO
  4. Koers ISCO
  5. Nieuws International Stem Cell Corp
  6. Andere talen